or Try an Advanced Search...

    Technical Analysis for CNTG - Centogene N.V.

    Grade Last Price % Change Price Change
    D 0.41 7.87% 0.03
    CNTG closed up 7.87 percent on Monday, July 1, 2024, on 19 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical CNTG trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Gapped Up Strength 0.00%
    Calm After Storm Range Contraction 7.87%
    50 DMA Resistance Bearish 5.02%
    New Uptrend Bullish 5.02%
    Gapped Up Strength 5.02%
    Upper Bollinger Band Touch Strength 5.02%
    50 DMA Resistance Bearish 5.10%
    Gapped Up Strength 5.10%
    Older End-of-Day Signals for CNTG ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 6 hours ago
    Rose Above Upper Bollinger Band about 6 hours ago
    50 DMA Resistance about 6 hours ago
    10 DMA Resistance about 6 hours ago
    Up 5% about 6 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CNTG Chart by TradingView
    Basic chart:

    Profile

    Centogene BV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services

    Is CNTG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 31 CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
    May 14 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
    May 10 CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
    Apr 2 Centogene receives Nasdaq non-compliance letter
    Apr 2 CENTOGENE Receives Nasdaq Non-Compliance Notice
    Feb 29 CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
    Feb 28 Centogene to explores strategic alternatives, gets Nasdaq delisting notice; shares plunge
    Feb 28 CENTOGENE Explores Strategic Alternatives
    Feb 28 CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
    Jan 24 CENTOGENE Receives French Research Tax Credit Accreditation
    See more CNTG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.655
    52 Week Low 0.34
    Average Volume 193,128
    200-Day Moving Average 0.86
    50-Day Moving Average 0.40
    20-Day Moving Average 0.38
    10-Day Moving Average 0.39
    Average True Range 0.04
    RSI (14) 54.75
    ADX 29.5
    +DI 27.80
    -DI 9.29
    Chandelier Exit (Long, 3 ATRs) 0.41
    Chandelier Exit (Short, 3 ATRs) 0.45
    Upper Bollinger Bands 0.41
    Lower Bollinger Band 0.35
    Percent B (%b) 0.96
    BandWidth 16.54
    MACD Line 0.00
    MACD Signal Line -0.01
    MACD Histogram 0.0058
    Fundamentals Value
    Market Cap 11.42 Million
    Num Shares 27.9 Million
    EPS -1.56
    Price-to-Earnings (P/E) Ratio -0.26
    Price-to-Sales 0.60
    Price-to-Book 0.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.45
    Resistance 3 (R3) 0.45 0.43 0.45
    Resistance 2 (R2) 0.43 0.42 0.43 0.44
    Resistance 1 (R1) 0.42 0.41 0.41 0.42 0.44
    Pivot Point 0.40 0.40 0.40 0.40 0.40
    Support 1 (S1) 0.39 0.39 0.38 0.40 0.38
    Support 2 (S2) 0.37 0.38 0.37 0.38
    Support 3 (S3) 0.36 0.37 0.37
    Support 4 (S4) 0.37